Literature DB >> 23642992

Psychotic disorders in DSM-5: summary of changes.

William T Carpenter1, Rajiv Tandon.   

Abstract

Key issues related to the diagnosis of schizophrenia and other psychotic disorders addressed in DSM-5 were more precisely defining diagnostic boundaries between different psychotic disorders, reducing spurious comorbidity, improving coherence across the diagnostic manual, and enhancing validity without loss of reliability. New information about the nature of these disorders generated since DSM-IV was incorporated into their definition. Resulting changes in DSM-5 include elimination of the classic subtypes of schizophrenia, elimination of special treatment of Schneiderian 'first-rank symptoms', more precise delineation of schizoaffective disorder from schizophrenia and psychotic mood disorders, and clarification of the nosologic status of catatonia and its consistent treatment across the manual. Changes in section 3 of the manual include addition of a new category of "attenuated psychosis syndrome" as a condition for further study and addition of unique psychopathological dimensions (that represent treatment targets across disorders). The specific nature of these revisions in the DSM-5 criteria for schizophrenia and other psychotic disorders along with their rationale are summarized in this article.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2013        PMID: 23642992     DOI: 10.1016/j.ajp.2013.04.001

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  10 in total

1.  Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia.

Authors:  Taina Mattila; Maarten Koeter; Tamar Wohlfarth; Jitschak Storosum; Wim van den Brink; Lieuwe de Haan; Eske Derks; Hubertus Leufkens; Damiaan Denys
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

2.  Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis.

Authors:  A Masillo; L R Valmaggia; R Saba; M Brandizzi; J F Lindau; A Solfanelli; M Curto; F Narilli; L Telesforo; G D Kotzalidis; D Di Pietro; M D'Alema; P Girardi; P Fiori Nastro
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-02-25       Impact factor: 4.785

3.  [Schizophrenia and other psychotic disorders in DSM-5: summary of the changes compared to DSM-IV].

Authors:  M Paulzen; F Schneider
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

4.  Severity of thought disorder predicts psychosis in persons at clinical high-risk.

Authors:  Diana O Perkins; Clark D Jeffries; Barbara A Cornblatt; Scott W Woods; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Robert Heinssen; Daniel H Mathalon; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Res       Date:  2015-10-04       Impact factor: 4.939

Review 5.  Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults.

Authors:  Amber Edinoff; Miriam T Ruoff; Yahya T Ghaffar; Arthur Rezayev; Devanshi Jani; Adam M Kaye; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2020-09-14

Review 6.  Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation.

Authors:  André Schmidt; Marco Cappucciati; Joaquim Radua; Grazia Rutigliano; Matteo Rocchetti; Liliana Dell'Osso; Pierluigi Politi; Stefan Borgwardt; Thomas Reilly; Lucia Valmaggia; Philip McGuire; Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

7.  Peripheral Blood Leukocyte RNA-Seq Identifies a Set of Genes Related to Abnormal Psychomotor Behavior Characteristics in Patients with Schizophrenia.

Authors:  Yunqiao Zhang; Xu You; Siwu Li; Qing Long; Yun Zhu; Zhaowei Teng; Yong Zeng
Journal:  Med Sci Monit       Date:  2020-02-10

8.  Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project.

Authors:  Diana O Perkins; Clark D Jeffries; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen
Journal:  Schizophr Bull       Date:  2014-08-06       Impact factor: 9.306

9.  Examination of categorical approach to symptom assessment: cross-validation of foulds' Delusions-Symptoms-States Inventory with Korean non-patient and patient groups.

Authors:  Samuel Suk-Hyun Hwang; Yeni Kim; Jae Seung Chang; Da Young Yun; Yong Sik Kim; Hee Yeon Jung
Journal:  BMC Psychiatry       Date:  2013-10-08       Impact factor: 3.630

10.  Catatonia in a patient with bipolar disorder type I.

Authors:  Ather Muneer
Journal:  J Neurosci Rural Pract       Date:  2014-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.